Skip to main content
. Author manuscript; available in PMC: 2012 May 10.
Published in final edited form as: Genet Epidemiol. 2010 Sep;34(6):582–590. doi: 10.1002/gepi.20515

Table 1.

Power for 500–2000 trios and 900,000 markers for a quantitative trait.

N Effect Equal weights
FBAT up-weighted
Wald up-weighted
trios Size FBAT Wald Liptak(1:1) Liptak(2:1) Liptak(3:1) Liptak(1:2) Liptak(1:3)
500 0.1 0.000 0.004 0.003 0.001 0.002 0.002 0.001
0.125 0.000 0.026 0.016 0.013 0.012 0.011 0.009
0.15 0.004 0.095 0.061 0.060 0.062 0.042 0.036
0.175 0.024 0.259 0.176 0.182 0.183 0.133 0.108
0.2 0.075 0.504 0.376 0.396 0.392 0.309 0.251

1000 0.1 0.008 0.058 0.041 0.054 0.049 0.033 0.024
0.125 0.043 0.265 0.210 0.242 0.231 0.172 0.136
0.15 0.172 0.637 0.547 0.587 0.577 0.467 0.402
0.175 0.417 0.906 0.853 0.879 0.869 0.786 0.721
0.2 0.712 0.987 0.972 0.983 0.980 0.948 0.917

2000 0.1 0.144 0.519 0.458 0.488 0.478 0.378 0.297
0.125 0.511 0.922 0.891 0.907 0.895 0.823 0.753
0.15 0.867 0.997 0.994 0.996 0.995 0.985 0.972
0.175 0.987 >0.999 >0.999 >0.999 >0.999 >0.999 >0.999
0.2 0.999 >0.999 >0.999 >0.999 >0.999 >0.999 >0.999

The standard FBAT test is denoted as “FBAT,” the population-based test is denoted as “Wald”, and our new integrated approach using both the population and family based information is denoted as “FBAT-Liptak. The numbers in parentheses, reflect the weighting of the FBAT component of the Liptak-CNV test relative to the Wald component of the Liptak-CNV, (e.g., (2:1) indicates that the FBAT component has twice the weight of the Wald component). The power reflects the proportion of replicates were the association p-value< 5.56×10−8.